16-2152855-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014353.5(RAB26):c.504C>A(p.His168Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000187 in 1,607,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014353.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000327 AC: 8AN: 244874Hom.: 0 AF XY: 0.0000300 AC XY: 4AN XY: 133362
GnomAD4 exome AF: 0.00000618 AC: 9AN: 1455680Hom.: 0 Cov.: 34 AF XY: 0.00000691 AC XY: 5AN XY: 723740
GnomAD4 genome AF: 0.000138 AC: 21AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 16, 2023 | The c.504C>A (p.H168Q) alteration is located in exon 6 (coding exon 6) of the RAB26 gene. This alteration results from a C to A substitution at nucleotide position 504, causing the histidine (H) at amino acid position 168 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at